Medicine prices spiral across Pakistan as essential drugs become unaffordable

KARACHI: A sharp rise in medicine prices across Pakistan is triggering growing concern among patients, healthcare professionals, and consumer rights groups, as the cost of essential drugs continues to climb amid inflationary pressure and rising operational costs.

From diabetes and blood pressure medicines to antibiotics, flu treatments, eye drops, and cardiac drugs, patients are increasingly struggling to afford routine healthcare needs in what experts describe as an escalating affordability crisis.

According to healthcare observers and market reports, the prices of several commonly used medicines have surged by more than 200% over recent months, with pharmaceutical companies reportedly implementing repeated price increases as fuel costs, import expenses, and economic instability continue to impact the healthcare supply chain.

The rising costs are particularly affecting patients suffering from chronic illnesses such as diabetes, hypertension, and heart disease, many of whom rely on continuous medication for survival and long-term treatment management.

Related story: Drug prices skyrocket after de-control policy

Medical professionals warn that growing financial pressure is forcing some patients to delay treatment, reduce prescribed dosages, or avoid purchasing medicines altogether — a trend experts say could lead to worsening health complications and increased hospitalizations in the future.

Among the medicines witnessing major price jumps are insulin products, antibiotics, cough syrups, calcium supplements, vitamin injections, allergy medicines, and skin treatments, further increasing concerns over access to essential healthcare for low- and middle-income families.

Related story: 'Medicine shortage eases in Pakistan following price deregulation'

Healthcare stakeholders have also raised concerns over the effectiveness of price monitoring mechanisms, questioning whether existing regulatory systems are adequately protecting consumers from unjustified medicine price hikes.

Consumer rights groups and public health advocates are now urging the government and the Drug Regulatory Authority of Pakistan (DRAP) to strengthen oversight, improve transparency in pharmaceutical pricing, and ensure the availability of affordable essential medicines across the country.

With inflation already impacting food, fuel, and utility costs, the continued rise in medicine prices is adding another layer of economic and emotional stress for millions of households dependent on long-term medical treatment.

Stay informed, stay alert

CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for real-time health alerts, expert insights, and breakthrough medical discoveries.